Who, what, when? Questions over Heartware ENDURANCE trial

Heartware's CEO said recently that the primary results for ENDURANCE will be delayed so that the data can be "comingled" with data from a supplemental cohort that includes a different primary end point and a key protocol difference. That's news to one of the primary investigators, who says he's still aiming to unveil ENDURANCE in late 2014.

Source: theHeart.org - August 19, 2013 Category: Cardiology Source Type: news